| 000 | 01839 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250515135320.0 | ||
| 264 | 0 | _c20090210 | |
| 008 | 200902s 0 0 eng d | ||
| 022 | _a1530-6860 | ||
| 024 | 7 |
_a10.1096/fj.07-104109 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCristofanon, Silvia | |
| 245 | 0 | 0 |
_aOxidative, multistep activation of the noncanonical NF-kappaB pathway via disulfide Bcl-3/p50 complex. _h[electronic resource] |
| 260 |
_bFASEB journal : official publication of the Federation of American Societies for Experimental Biology _cJan 2009 |
||
| 300 |
_a45-57 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aB-Cell Lymphoma 3 Protein |
| 650 | 0 | 4 | _aButhionine Sulfoximine |
| 650 | 0 | 4 |
_aGene Expression Regulation _xphysiology |
| 650 | 0 | 4 |
_aGlutathione _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aI-kappa B Kinase _xmetabolism |
| 650 | 0 | 4 |
_aMonocytes _xdrug effects |
| 650 | 0 | 4 |
_aNF-kappa B _xmetabolism |
| 650 | 0 | 4 |
_aNF-kappa B p50 Subunit _xmetabolism |
| 650 | 0 | 4 | _aOxidation-Reduction |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins _xmetabolism |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-bcl-2 _xmetabolism |
| 650 | 0 | 4 | _aReactive Oxygen Species |
| 650 | 0 | 4 |
_aTranscription Factor RelA _xgenetics |
| 650 | 0 | 4 |
_aTranscription Factors _xmetabolism |
| 650 | 0 | 4 | _aU937 Cells |
| 650 | 0 | 4 |
_ap38 Mitogen-Activated Protein Kinases _xmetabolism |
| 700 | 1 | _aMorceau, Franck | |
| 700 | 1 | _aScovassi, A Ivana | |
| 700 | 1 | _aDicato, Mario | |
| 700 | 1 | _aGhibelli, Lina | |
| 700 | 1 | _aDiederich, Marc | |
| 773 | 0 |
_tFASEB journal : official publication of the Federation of American Societies for Experimental Biology _gvol. 23 _gno. 1 _gp. 45-57 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1096/fj.07-104109 _zAvailable from publisher's website |
| 999 |
_c18264769 _d18264769 |
||